INTRODUCTION
Wasting of body tissue may arise either because of inadequate nutrient intake or as a consequence of a disease state such as infection, injury, cancer or chronic inflammation. The body responds to inadequate macronutrient intake by 'appropriate' metabolic responses such as reduced energy expenditure and preferential utilization of fat for energy in such a way as to conserve vital (lean) tissues. In contrast, in chronic inflammatory states, the metabolic changes, such as increased energy expenditure, are considered dysregulatory and contribute to the pathological state, rather than resulting in its amelioration. Changes in protein metabolism, in particular, appear to be counter-regulatory in inflammatory states, as first described by Cuthbertson in the 1930s [l]. Protein breakdown is accelerated and the liberated amino acids are oxidized for energy resulting in increased nitrogen excretion. Although such liberation of amino acids from tissue may have beneficial effects, such as providing a rapid supply of substrate for acute phase protein synthesis, immune cell proliferation and activation or repair of damaged tissues, the consequence of increased nitrogen excretion is depletion of whole body protein and this results in loss of lean tissue with adverse effects on the function of several tissues, particularly skeletal muscle. In developing countries, malnutrition and chronic infection often co-exist and the inflammatory response may impair the adaptive response to malnutrition.
The rate of loss of protein from the body represents the difference between the rate of protein breakdown into amino acids and the rate of synthesis of new proteins from amino acids. The rate of breakdown and resynthesis is known as turnover. When whole body protein turnover is considered, malnutrition and inflammation tend to have opposite effects. Acute reduction in food intake has been associated with reduced turnover of protein and nitrogen conservation [2] . However, in chronic energy deficiency, when a new steady-state weight has been reached, protein turnover may be normal or high when expressed per unit lean body mass [3, 41. Such an effect may be the consequence of altered composition of the lean body compartment. As wasting occurs there is preferential loss of the somatic (muscle) component so that the proportion of visceral to somatic protein comprising lean body mass is increased. As visceral tissues have higher rates of turnover per unit mass, whole body rates are increased. Thus changes in body composition and metabolism must be considered together.
Inflammatory states tend to accelerate protein turnover. Such an effect has been described in human studies in acute sepsis [5] , pulmonary infection in cystic fibrosis [6] , HIV infection [7] , melioidosis [8] , measles in children [9] , and after vaccination [lo] . Large increases in protein turnover are similarly seen in other catabolic states such as burns [ll] , trauma [12, 131 and malignancy [14, 151 . The increase in resting energy expenditure seen in such states may, at least in part, be attributed to the energy cost of increased turnover of protein. However, accelerated protein turnover is not always associated with increased net breakdown. In HIV infection, for example, protein turnover was increased in subjects who were weight stable or regaining weight during recovery from opportunistic infection and therefore conserving rather than losing body protein [7] .
The wasting seen in inflammatory states is frequently compounded by reduced nutrient intake so that a combination of pathophysiological mechanisms are involved. However, restoration of intake to normal or above normal levels does not result in a restoration of protein balance. Rather the increased amino acid intake is diverted to oxidation and excretion and the increased energy content is deposited as fat rather than lean tissue while breakdown of body protein continues unabated [16] . Such 'anabolic block' has been described in animal models [17] and septic intensive care patients [16] . In patients with AIDS, however, direct measurement of amino acid kinetics demonstrated an appropriate quantitative response to nutrition during phases of weight stability, weight loss and weight recovery [7] . Aggressive nutrition support with total parenteral nutrition in AIDS patients resulted in accretion of lean tissue according to body composition studies in patients with gastrointestinal complications but not in those with active systemic infection [18] . Such observations suggest that HIV infection itself does not induce 'anabolic block' but imply that secondary systemic infections may do so.
The archetypal wasting condition might be considered to be tuberculosis. Tuberculosis (TB) was known to the Greek physicians as 'phthisis', meaning literally 'to waste away', and in the 18th and 19th century TB became commonly known as 'consumption', although this term was probably also applied to several other chronic infectious conditions. On a global level, TB remains a major health problem, estimated to cause about 8.8 million new cases and 3 million deaths per annum [19] . TB is a major contributor to the wasting that accompanies HIV infection in 'Slim disease' [20] . Clearly the treatment of the wasting associated with TB is the treatment of the infective process; when this is effective, spontaneous weight gain occurs. However, in the pretreatment phase, TB represents a clinical model of chronic inflammatory wasting. We therefore chose to study the metabolic response to TB in order to shed light on the common metabolic features of wasting due to chronic infection.
In order to investigate the pathophysiology of wasting in chronic inflammatory conditions we performed a study of protein metabolism in a group of patients with pulmonary TB in South India. In order to separate those effects due to inadequate food intake and altered body composition from those due to the infective process we compared TB subjects with a group of anthropometrically matched subjects with chronic energy deficiency due to poverty and with a group of normal well-nourished Indian control subjects.
Our hypotheses were that protein turnover would appear to be accelerated in the undernourished subjects, reflecting their altered body composition, and would be further increased in the TB patients because of the added inflammatory stimulus. We postulated that resting energy expenditure would demonstrate a similar pattern. In addition, we hypothesized that TB patients would show an impaired anabolic response to feeding when compared with either of the non-TB groups -the 'anabolic block' hypothesis -and this would manifest itself as an increase in the proportion of protein intake oxidized, rather than utilized for protein synthesis, in the fed phase.
METHODS

Subjects and clinical evaluation
Studies were performed at the Nutrition Research Centre, St. John's Medical College, Bangalore, South India. Subjects were recruited into three groups: normal controls, chronically undernourished subjects, and patients with TB. General entry criteria were: age 18-65years, either male or female. Power testing, based on estimates of likely variance in indices of protein metabolism from previous studies [7] , suggested that at least six subjects would be required in each group.
Normal controls were recruited from the local population and were defined as being clinically well and having a body mass index (BMI) of at least 20 kg/m2. Undernourished subjects with chronic energy deficiency were recruited from a local area of poor housing and were defined as being clinically well and having a BMI of 18.5 kg/m2 or less. Normal and undernourished subjects were interviewed and excluded if there was any history of ongoing clinical symptoms or current medical treatment or if they had a fever on the study day. Chest radiography was not performed on these groups but none had symptoms or signs of TB or other infection. Bangalore is not an area with a high prevalence of malaria and this study was performed outside the malaria season.
Subjects with pulmonary TB were recruited from outpatient clinics and inpatient admissions to St. John's Medical College Hospital over a 4month period. Diagnosis was based upon clinical presentation confirmed by positive sputum microscopy for acid-fast bacilli or appropriate radiology. The intention was to perform metabolic measurements as soon as possible after diagnosis of TB, and certainly within 2 days of commencing treatment. Often it was possible to perform measurements of protein metabolism before anti-tuberculous treatment was commenced. For ethical reasons it was considered inappropriate to delay treatment because the patient was entered in the study; in fact, entry to the study frequently expedited treatment by hastening the diagnostic process. Anti-tuberculous therapy consisted of rifampicin, isoniazid and pyrazinamide in all cases where therapy was commenced. Exclusion criteria were: clinically apparent extrapulmonary TB, anti-tuberculous therapy in the last 6 months, hyperglycaemia, markedly abnormal liver function tests (except for hypoalbuminaemia), and HIV seropositivity. HIV serology was performed by ELISA (Wellcome Pharmaceuticals, Crewe, U.K.) in all TB subjects; for ethical reasons, controls and undernourished subjects were not tested for antibodies to HIV but at the time of the study the incidence of HIV infection in the community around Bangalore was not high.
Ethical approval
Ethical approval was given by the local Medical Ethics committee and informed consent was obtained from all subjects.
Cytokine assays
In order to investigate the possible role of circulating cytokines in modulating protein metabolism, plasma levels of tumour necrosis factor-a (TNF-a), interleukin-6 (IL-6) and interleukin-8 (IL-8) were measured in plasma samples frozen immediately after blood drawing. TNF-a bioactivity was measured by cell-lysis bioassay using the WEHI 164 cell line, subclone 13 [21] . IL-6 was measured by cell proliferation using B9 cells [22] . IL-8 was measured by ELISA [23] . Lower limits of detection for TNF-a, IL-6 and IL-8 were 7, 1.5 and 50 pg/ml respectively.
In addition, C-reactive protein was assayed by nephelometry in all subjects.
Measurement of energy expenditure
Energy expenditure was measured by ventilated hood indirect calorimetry using a Datex 'Deltatrac' metabolic monitor (Datex Instrumentarium Corp. Helsinki, Finland). Measurements of resting energy expenditure (REE) were made under strict basal conditions after an overnight fast, immediately before cannulation and measurement of protein turnover. Results were evaluated using standard calorimetric equations and compared with predicted resting metabolic rate using the predictive equations of and Schofield [25] . In addition, respiratory gas exchange was measured during the fasting and fed plateau phases of the protein turnover study, from 2 to 4 h and 6 to 8 h respectively after commencement of the leucine infusion, using a 500 1 tent as previously described [7] , rather than the standard hood to allow greater subject comfort. Sleep, small amounts of movement and conversation were allowed during these phases, which were thus not 'basal' but activity levels were similar in the two phases in all subjects. Total COZ production rate was used to estimate the leucine oxidation rate. Calibration of the calorimeter with both hood and tent was performed on every study day by burning a weighed amount of ethanol.
Protein metabolism from ['3C]leucine kinetics
Protocol. The experimental protocol was similar to that described previously [7, 14, 261 and consisted of an 8 h study period throughout which L-[ l-13C]leucine (99 atom %; Tracer Technologies, Somerville, MA, U.S.A.) was infused at a rate of 2.3 pmol.h-'.kg-', after a priming dose of 2.88 pmolkg. Subjects were studied after an overnight fast and remained fasted for the first half (4 h) of the protocol (post-absorptive phase). In the second half of the study period (4 h), subjects were fed hourly meals as described below. Separate cannulae, sited in the forearm veins of opposite arms, were used for infusion of isotope on one side and blood sampling on the other. Breath samples were taken by transfer into evacuated tubes. Samples of blood and breath were taken half-hourly during the plateau phases, previously demonstrated to be reached during hours 2-4 in the post-absorptive phase and hours 6-8 in the fed state [7, 14, 261 .
Analysis. Isotopic enrichments of [ 13C]leucine and
[ 13C]cr-ketoisocaproic acid (KIC), the deamination product of leucine, in serum were measured by GC/MS (VG12-250, VG Masslab, Altrincham, Cheshire, UK). Isotopic enrichment of 13C02 was mea-sured by gas isotope ratio MS (Europa Scientific, Crewe, Cheshire, U.K.). Breath 13C02 enrichment was calculated in the post-absorptive state as the difference from preinfusion values. In the fed state, enrichment was calculated by subtraction of the enrichment seen at the same time points in individuals receiving an identical oral nutrition regimen but without [13C]leucine infusion.
Calculation of whole body protein turnover. Rates of whole body leucine metabolism were calculated as described previously [26, 271 . Leucine flux was calculated as the measured rate of tracer infusion divided by the plateau serum enrichment of either [13C]KIC or [13C]leucine; since there is uncertainty regarding the true precursor enrichment for whole body protein turnover, both sets of values are shown in the results. Leucine oxidation was the product of the rate of C02 production and the brTath 13C02 enrichment at plateau, divided by the serum enrichment of [13C]KIC as the precursor for leucine oxidation. The labelled C02 production rate was corrected for incomplete recovery using figures previously published for a similar protocol of 0.74 and 0.87 for post-absorptive and fed phases respectively [26, 271 . Both flux and oxidation rate were expressed after subtraction of the rate of infusion of leucine to derive the endogenous flux and oxidation rates, assuming that infused leucine was entirely oxidized.
In the model used there are only two possible fates for the labelled carbon of [ l-13C]leucine, incorporation into body protein or decarboxylation and release as 13C02. Thus, the rate of incorporation of leucine into body protein was calculated from the difference between the rate of oxidation and flux; this value, which may be referred to as non-oxidative leucine disposal, was taken to be equal to the rate of whole body protein synthesis. This model has recently been validated for the measurement of protein kinetics by El-Khoury et al. . The rate of release of leucine from protein breakdown was calculated from the difference between flux and dietary intake plus infused intake. Protein balance was taken as the difference between the rate of protein synthesis and the rate of protein breakdown, as measured by leucine kinetics [28]; it was thus equal to the endogenous oxidation rate in the fasted state and the difference between the oxidation rate and the dietary intake rate in the fed state.
Normalization for body mass. In order to make comparisons between individuals or between groups it was necessary to express protein metabolism in terms of body mass. As lean tissue is the primary metabolically active compartment, lean body mass was used as denominator, as in previous studies [7, 141. Lean body mass was calculated by subtracting percentage body fat from total body weight, measured with digital electronic scales. Percentage body fat was estimated from four-site skinfold measurements, performed by a single observer, using predictive equations [31] .
Oral nutritional administration
Subjects remained fasting from 0 to 4 h of the leucine infusion and were then fed hourly meals from hours 4 to 8. The feeding regime consisted of bread, butter and a locally produced high-protein, soya-based feed given as a drink with water ('Ten-0-lip', Criticare Laboratories Pvt. Ltd, Bombay, India; macronutrient composition per 100 g dry weight: 18.8g of protein, 7 g of fat and 66.3g of carbohydrate). This was chosen to provide a high nitrogen intake in a consistent, measurable and reproducible fashion. The quantity given was based on body weight in order to give a similar anabolic stimulus to all subjects. Each hourly meal consisted of 0.31 g of bread, 0.07g of butter and 0.37g of 'Ten-0-lip7 per kg body weight. This diet was designed to provide approximately 1.5 x basal metabolic rate (estimated at 92.0 kJ/day per kg total body weight) for the whole 8 h protocol during the 4 h fed phase. Oral nutrition thus provided 11.5 kJ . h-I kg-' energy; proportional contributions were protein 15%, fat 30% and carbohydrate 55%. Protein intake over the 8 h period (all given during the 4 h fed phase) was 0.18 g of N/day per kg, equivalent to 10.8 g of N/day for a 60 kg subject.
Substrate utilization
Utilization rates for the three major substrates, Carbohydrate, fat and protein, were calculated from respiratory gas analysis and from the leucine oxidation rate using the stoichiometric approach described by Garlick et al. [27, 321 . Values were expressed both in terms of amount of each substrate utilized and the relative contribution to energy supply assuming energy values of 39.1, 15.7 and 18.4 kJ/g for fat, carbohydrate and protein respectively.
Comparisons
Data are expressed as means S.D. Statistical comparisons for differences between the three groups were made by analysis of variance and, if significant, post-hoc comparisons were made by Fisher's PLSD test. Comparisons between fasted and fed phases were made by paired t-tests. Correlations were determined by simple linear regression. Cytokine concentration data, which was not normally distributed, was compared by Mann-Whitney U-test.
RESULTS
Subjects and clinical characteristics
Twenty-two subjects were studied over a 3 month period: seven normal control subjects, six chronically undernourished subjects and nine patients with TB. Characteristics and anthropometric indices of sub-jects are shown in Table 1 . The undernourished control group, by virtue of the way they were recruited, came from a fairly uniform group of thin young men. They were younger than the control and TB groups but were well matched for weight, lean body mass, percentage fat and BMI with the TB group.
Subjects with pulmonary TB generally had a 1 week to 2 month history of respiratory symptoms. Clinical details of TB subjects are shown in Table 2 . Six of the nine subjects were sputum positive for acid-fast bacilli. Of the three subjects who were negative for acid-fast bacilli, one (Pl) had characteristic radiographic changes and responded promptly to treatment, one (P5) had caseating granuloma on endobronchial biopsy and one (P9) had a high protein, lymphocytic pleural effusion and also made a prompt response to therapy; based on these criteria they were diagnosed as having pulmonary TB.
Four of the nine had a fever of greater than 38°C on the day of investigation. None of the control or undernourished subjects had a pyrexia on the study day. Most TB patients had an elevated erythrocyte sedimentation rate (mean 59 & 37 mm/h, n = 7). Mean peripheral blood leucocyte count was 9.2 & 2.7 x 109A (n = 8). C-reactive protein was ele- were found in subjects in either the control or undernourished groups.
Plasma cytokine concentrations
TB patients had elevated circulating levels of IL-6 but not TNF-a or IL-8. Cytokine concentrations were not normally distributed within groups so nonparametric comparisons were made. The median IL-6 in TB patients, 103.0 pg/ml (interquartile range 73.0 pg/ml), was higher than that seen in controls, 56.0 (18.3) pg/ml, or undernourished subjects, 32.5 (19.0) pg/ml (P = 0.003 and P = 0.013 respectively by Mann-Whitney U-test). TNF-a concentrations of 10-20 pg/ml were seen in all groups but there were no significant differences between groups. IL-8 was not found in any samples; the lower limit of detection was 50 pg/ml.
Energy metabolism
Resting energy expenditure, when expressed per kg of lean body mass, was elevated in both the undernourished (+ 19.5% relative to controls) and TB (+21.2%) groups. Similar elevations, relative to the control group, were seen when REE was expressed as a proportion of predicted REE ( Table  3) . The scatter within the TB group was much greater than in the other groups. The elevation in REE was almost identical in the undernourished and TB groups despite the observation that half of the TB subjects were febrile at the time of measurement. A large component of the hypermetabolism in the TB subjects might thus be due to their altered body composition rather than the inflammatory state or fever per se. The relationship between REE per Fig. l(a) . TB subjects were scattered equally above and below the regression line for the two non-TB groups.
A similar pattern of differences was seen during the leucine infusion when the tent was used to collect respiratory gases ( an increase in energy expenditure in all groups (mean increase 18%) and an increase in respiratory quotient, although this was not significant in the undernourished group.
Protein metabolism
Methodological considerations. Infusion of [ '3C]leucine typically achieved serum leucine enrichments of about 2%; individual values are shown in Table 4 . Mean leucine enrichments for all subjects were 2.10+0.37% fasted and 1.82k0.22 fed; for KIC enrichment, values were 1.83 f 0.27 fasted and 1.64 +0.22% fed. Plateaux were confirmed visually from enrichment plots; average variances within plateaux (the mean S.D.s as a proportion of the mean enrichments) were 6.2 and 6.6% for leucine, and 4.4 and 5.5% for KIC, fasted and fed respectively ( Table 4 ). The mean KICAeucine ratios were 0.88+0.09 fasted and 0.91 k0.10 fed and, as expected, analyses based on KIC and leucine enrichments gave similar results (Table 5) .
Whole body protein metabolism. Parameters of whole body protein metabolism derived from leucine flux are summarized in Table 5 . Values are expressed as pmol leucine per hour per kg lean body weight. Since most human tissue proteins contain about 0.61 mmol leucine per g of protein [27] , 1 pmol leucineh per kg can be considered equivalent to about 1.64 mg proteinh per kg.
Fasting whole body protein turnover. Fasting leucine flux was taken as a measure of the rate of whole body protein turnover. When expressed in terms of lean body mass, whole body protein turnover was 14% greater in the undernourished group than in the well-nourished control subjects (P = 0.014). This was associated with similar increases in the rates of protein breakdown and synthesis (P = 0.041); thus the rate of oxidation, which in the fasted state is equal to the net balance, was Undernourished (n = 6) no different between the groups. TB patients had similar rates of turnover, synthesis and breakdown to those seen in well-nourished control subjects, despite the fact that in anthropometric terms, they more closely resembled the undernourished controls. Figure l(b) shows the correlation of protein turnover with body composition. Most values for the TB subjects were found to lie below the regression line for the two non-TB groups suggesting that the rate of turnover was even less than might be predicted from non-TB subjects, although the group mean for TB subjects did not differ significantly from either the control or undernourished group. There was no significant relationship between protein turnover and REE when analysed in the two non-TB groups or across all three groups. There was a trend towards higher values of fasting leucine oxidation, and thus net balance, in the TB group although this was not significant (P = 0.28 by analysis of variance; Table 5 ).
Response of protein metabolism to nutrition. In all groups, oral feeding resulted in a switch from net protein catabolism to net protein anabolism. This switch was mediated primarily by a reduction in the rate of protein breakdown which was similar in the three groups, a fall of 36%, 33% and 39% respectively in the control, undernourished and TB groups. Feeding was associated with an increase in leucine flux in the control and TB groups but no significant increase in protein synthesis in any group (Table 5) .
Feeding stimulated an increase in leucine oxidation in all groups. This increase in oxidation represents the excess of amino acid intake over the requirements for increased net anabolism in the fed phase. Fed phase leucine oxidation in the TB group (47.0 f 10.5 pmol . h-' * kg-') was 27% higher than in the control group (37.1 k5.4 pmol-h-'.kg-', P = 0.074; Table 5 ) corresponding to a less positive protein balance in the TB group in the fed phase, 24.5 versus 39.7 pmol. h-l-kg-' (P = O.Ol).Thus the magnitude of the change from net catabolism to net anabolism on feeding (the change in 'balance' from negative to positive) was less in the TB group than in the control group, +49.9 versus +60.5 pmol h-' kg-' (P = 0.042). The undernourished group had intermediate values for both oxidation and balance. In terms of the change in balance from fasting to fed state, the value for the undernourished group, +52.3 pmol . h-' ekg-', was not significantly different from either the control or the TB group (P = 0.15 and 0.69 respectively).
An alternative approach to assessing differences in protein metabolism between individuals is to express leucine oxidation relative to leucine flux. This approach has the advantage of avoiding the use of a body mass denominator and also has real meaning in physiological terms. Leucine in the plasma pool has two potential fates; it may either be reincorporated into body protein and thus be retained by the body or it may be oxidized and thus lost to the body protein pool. The ratio of oxidation to flux gives a measure of the probability that a leucine molecule passing through the plasma pool will be directed towards oxidation rather than being reincorporated into protein.
When expressed in this way, it can be seen that in the fed state TB subjects oxidized a greater proportion of leucine flux than did either non-TB group (33% versus 24% for both well-nourished and undernourished groups; P = 0.017 and 0.038 respectively, based on leucine values). This difference is not apparent in the fasted state and thus reflects disposal of food rather than differing metabolism of body protein. Expressed as the converse, 76% of leucine flux is reincorporated into protein in the control and undernourished groups while this value is only 67% in the TB group. Thus a greater proportion of absorbed protein from food is oxidized rather than being utilized for protein anabolism in subjects with TB. The effects of feeding on leucine oxidation are summarized in Fig. 2 .
Fuel utilization
Combining the rate of protein oxidation, from the rate of 13C02 production, with respiratory gas analysis, it was possible to calculate the relative contributions of the major macronutrients to energy metabolism using a stoichiometric approach. These values were expressed both in terms of the amount of each substrate utilized per unit lean body mass and as percentage contribution to total energy CQlmibutiOn to enwgy (%) metabolism (Table 6 ). In the fasting state, subjects with TB tended to utilize fat for energy to a greater extent than did well-nourished controls, 1.89 versus 1.27 g.day-'.kg-' (P = 0.025), although when compared with undernourished controls (1.53 g .
day-' -kg-I), this effect was not significant
Feeding did not result in significant changes in the proportional utilization of macronutrients, except in the TB group, where the utilization of fat for fuel dropped from 49.8 to 20.5% (P<O.Ol). In the fed phase, the proportional contribution of each macronutrient to energy supply tended to more closely resemble that of the food itself rather than the fasting pattern; the energy distribution of the food was carbohydrate 55%, fat 30% and protein 15%. All groups stored all three macronutrients (shown as a positive balance in Table 6 ) during the fed phase indicating an adequate anabolic stimulus. Carbohydrate storage was lower in the TB and undernourished groups compared with normal controls and this was associated with increased oxidation of carbohydrate in the fed phase. Utilization of protein for energy increased in all groups and protein anabolism was reduced in the undernourished and TB groups, particularly in the TB group, as described above.
DISCUSSION
Both undernutrition and TB result in wasting but they perturb protein and energy metabolism in different ways. Undernutrition results in metabolic changes that tend to conserve energy and protein while inflammatory or 'cachexic' states appear to waste energy and protein [2] . Both states result in altered body composition which itself influences the metabolic profile of the individual [3, 41. Our primary finding in this study was that, given the same anabolic stimulus, TB patients utilized a lesser proportion of the ingested amino acids for protein synthesis than non-TB subjects suggesting that there is inhibition of the normal anabolic response to nutrition.
In Indian subjects with chronic energy deficiency we found that both energy expenditure and protein turnover were reduced when expressed in absolute terms. However, wasted individuals are smaller and such data must therefore be corrected for body magnitude in order to reveal physiological changes. The amount of metabolically active tissue is reflected more accurately by lean body mass than by body weight. When expressed per kg lean body mass, our undernourished subjects were found to have increased energy expenditure and accelerated whole body protein turnover. This accords with previous measurements in similar subjects using ['5N]glycine which revealed normal or high rates of energy and protein metabolism [3, 41. Such an observation might be considered contrary to the widely held view that undernutrition results in adaptive changes to conserve energy and protein [2] . However the increases in energy and protein metabolism seen in this study are more likely to be the result of changes in body composition than metabolic changes within tissues themselves. Lean body mass is comprised of visceral mass (liver, gut, heart, lungs, brain) and somatic mass (predominantly skeletal muscle). At rest, visceral tissue is far more metabolically active per unit mass than somatic tissue. In chronically undernourished individuals visceral tissue tends to be conserved while somatic muscle tissue is depleted [3, 41 . Thus values for energy and protein metabolism expressed per kg of lean body mass tend to be elevated. When using [15N]glycine as a tracer, this is reflected by an elevated ratio of urea to ammonia flux, as previously described [4] . Such increased protein turnover in undernourished subjects is unlikely to be due to occult infection as C-reactive protein levels were not elevated in any undernourished subjects.
TB, in contrast, did not result in accelerated whole body protein turnover or elevated energy expenditure despite the presence of fever in several subjects during the measurement period. This contrasts with observations in other infective and inflammatory states as discussed in the Introduction [S, 6, 9, 101, and in particular contrasts with findings in HIV infection where a 25% increase in whole body protein turnover was demonstrated using an identical methodology [7] . Thus it appears that different inflammatory states give rise to different patterns of metabolic response. The concept of a 'common response' to injury and inflammation has yielded much useful information since Cuthbertson's seminal studies [l] but it may now be necessary to begin to differentiate our classification of the pattern of metabolic response according to disease type rather then unifying such responses together in a single category. Such categorization may reflect differences in cytokine responses seen in different pathologies since these agents are believed to be pivotal in mediation of the effects of inflammation. In this study, for example, raised plasma levels of IL-6 but not TNF-a were seen whereas in the subjects with HIV infection previously investigated, the opposite pattern, i.e. high TNF-a and low IL-6, was observed [7] .
In all subjects, feeding with oral nutrition resulted in a switch from net protein loss to net accumulation at the whole body level. This was primarily mediated by a reduction in the rate of protein degradation, as previously described [26] . In the fed state, the excess amino acid intake above that utilized for increased net protein synthesis must be oxidized, as amino acids can only be 'stored' as protein; the 'storage' capacity of the circulating amino acid pool is negligible as plasma concentrations of amino acids appear to be tightly regulated. In all groups, intake (mean 72.1 pmol. h-I kg-') exceeded the increase in net protein synthesis and an increase in oxidation was seen ( Table 5 ) . In subjects with TB, the increase in oxidation was greater such that in the fed phase 33% of amino acid flux was directed towards oxidation while in the non-TB groups this figure was only 24%. For the TB group the increase in protein synthesis, when expressed as the change from the fasted to the fed state, accounted for about 70% of the increased amino acid supply from food; thus about 30% of intake was accounted for by increased oxidation. In the control and undernourished groups the proportions of amino acid intake accounted for by increased net protein synthesis were 79% and 78% respectively. Thus given the same anabolic stimulus TB patients utilized a lesser proportion of the ingested amino acids for protein synthesis than non-TB subjects. This would support the hypothesis that there is a block to the anabolic response to nutrition in TB patients.
The mechanism of such a block remains unclear. At the molecular level, muscle from septic rats has normal levels of mRNA for structural proteins but synthetic rates are reduced suggesting that the block is at the translational level [33, 341 . Total muscle RNA is reduced in lipopolysaccharide-treated rats, suggesting loss of ribosomes, and such reduction in the synthetic machinery may have a direct impact on protein synthesis [33] . Anabolic hormones were not measured in this study but are likely to be involved; insulin resistance may be partly responsible and could perhaps explain the contrast with HIV infection where 'anabolic block' was not demonstrated by the same technique [7] and where the typical 'septic' insulin resistance pattern is not seen [35] . In addition, activation of specific cytokines which suppress muscle protein synthesis and stimulate protein breakdown may be involved.
TNF-a has been implicated as a mediator of wasting in inflammatory conditions. TNF-a levels are high in patients infected with HIV and those co-infected with TB and HIV [36] . Blockade of TNF-a production with thalidomide results in weight gain in both HIV infection and HIV/TB co-infection [36] . In this study of non-HIV-related TB, the absence of elevated plasma TNF-a levels suggests that mediators other than TNF-a are likely to be involved, although the pulsatile nature of TNF-a release means that transient elevation of TNF-a may have passed undetected. TNF-a receptor levels were not measured in this study. IL-6 is known to be pivotal in the regulation of hepatic protein synthesis in the acute phase response, directing secretory protein synthesis away from albumin and towards acute phase proteins by means of alterations in specific mRNA levels [37] . IL-6 is therefore likely to be a major factor determining the balance between protein synthesis and breakdown in inflammatory states such as TB.
Analysis of substrate utilization demonstrated greater utilization of fat for energy in the fasting state in TB-infected subjects, as has been observed with other inflammatory conditions such as HIV infection [38] . Although not measured in this study, plasma triacylglycerol levels are commonly elevated in infection [39] due to specific cytokine-regulated increases in de novo lipogenesis and such elevated levels may be responsible for the increased oxidation of fat [40, 411. This study provides evidence, from in vivo measurements of [ 13C]leucine flux in man, that infection with TB results in a diversion of ingested amino acids away from utilization for protein synthesis and thus towards oxidation with consequent loss from the body protein pool. Such wasting of protein was not associated with increased whole body protein turnover as reflected by amino acid flux. The primary treatment of the wasting associated with TB is anti-mycobacterial treatment of the infection itself. However, malnutrition often exacerbates the clinical condition and recovery is frequently slow. Anabolic agents which might overcome such anabolic block may therefore have a role to play in management and may hasten immunological recovery and mycobacterial clearance in patients with TB. 
